BIFIDOBACTERIUM FOR USE IN INFLUENCING LOW-GRADE INFLAMMATION

Patent Number: WO-2024003038-A1

Publication Year: 2024

Application Year: 2023

Priority Year: 2022

Jurisdictions: WO

Status: N/A

Inventors:

ENGEL SARA DAMHOLT ANDERS

Applicants:

  1. Chr. Hansen (Denmark)
  2. [NORA names: Novonesis; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

The present invention generally relates to human therapeutic effects of Bifidobacterium adolescentis, and particularly alleviating of low-grade inflammation in an elderly population.

Patent Family Records (1)

BIFIDOBACTERIUM FOR USE IN INFLUENCING LOW-GRADE INFLAMMATION

CHR HANSEN AS, Chr. Hansen (Denmark) ENGEL SARA, DAMHOLT ANDERS

2024, WO-2024003038-A1

Data Provider: Digital Science